Global Pyrotinib Maleate Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Pyrotinib Maleate market size was valued at US$ 227 million in 2025 and is forecast to a readjusted size of US$ 497 million by 2032 with a CAGR of 9.8% during review period.
In 2025, global Pyrotinib Maleate production reached approximately 420,000 units.Pyrotinib maleate is an oral small-molecule targeted anticancer drug and an irreversible inhibitor of the human epidermal growth factor receptor (HER) family. It exerts its antitumor effects primarily by simultaneously inhibiting HER1, HER2, and HER4 signaling pathways. Clinically, it is mainly used for the treatment of HER2-positive breast cancer, particularly in patients who have previously received anti-HER2 therapies such as trastuzumab. Pyrotinib maleate blocks tumor cell proliferation signaling pathways, thereby inhibiting tumor growth and delaying disease progression. It is commonly used in combination with other chemotherapeutic agents to enhance therapeutic efficacy and improve patient outcomes. With the advancement of precision medicine and the growing adoption of targeted therapy concepts, the clinical value of pyrotinib maleate in oncology continues to increase.
Pyrotinib Maleate is an irreversible pan-HER tyrosine kinase inhibitor primarily used for the treatment of HER2-positive breast cancer, demonstrating strong competitiveness in China’s oncology targeted therapy market. With the increasing rate of early breast cancer screening and the widespread adoption of HER2 testing, the demand for precision medicine continues to grow, providing a solid clinical foundation for this drug.
From a market landscape perspective, anti-HER2 monoclonal antibodies such as Trastuzumab and Pertuzumab, as well as antibody-drug conjugates (ADCs) like T-DM1, occupy important positions. However, as an oral small-molecule TKI, pyrotinib maleate shows favorable efficacy and convenience, particularly in patients with advanced disease or those who have failed prior therapies. In addition, its inclusion in the national reimbursement drug list helps improve patient accessibility and expand market penetration.
On the policy side, volume-based procurement and healthcare cost-control measures exert downward pressure on drug pricing while also driving increased market uptake. From a competitive standpoint, the continuous emergence of similar HER2-targeted therapies from both domestic and international players is intensifying market competition. Therefore, the future market performance of pyrotinib maleate will depend on its progress in combination therapies, expansion of indications (such as HER2-mutant lung cancer), and accumulation of real-world evidence, as well as its overall balance of efficacy, safety, and pricing competitiveness.
This report is a detailed and comprehensive analysis for global Pyrotinib Maleate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pyrotinib Maleate market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Pyrotinib Maleate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Pyrotinib Maleate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Pyrotinib Maleate market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pyrotinib Maleate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pyrotinib Maleate market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangsu Hengrui Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pyrotinib Maleate market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
80 mg/tablet
160 mg/tablet
Market segment by Release Type
Immediate-release (IR)
Sustained-release (SR)
Market segment by Sales Channel
Hospital
Retail
Online
Market segment by Application
HER2-positive Breast Cancer
Advanced or Metastatic Breast Cancer
Others
Major players covered
Jiangsu Hengrui Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pyrotinib Maleate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pyrotinib Maleate, with price, sales quantity, revenue, and global market share of Pyrotinib Maleate from 2021 to 2026.
Chapter 3, the Pyrotinib Maleate competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pyrotinib Maleate breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pyrotinib Maleate market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pyrotinib Maleate.
Chapter 14 and 15, to describe Pyrotinib Maleate sales channel, distributors, customers, research findings and conclusion.